His primary areas of study are Pancreatic cancer, Pancreas, Cancer research, Internal medicine and Surgery. His research on Pancreatic cancer concerns the broader Cancer. His Pancreas research is multidisciplinary, incorporating elements of Abscess, Complication, Cell cycle, Pancreatitis and Adenocarcinoma.
His research integrates issues of Carcinogenesis, Apoptosis, Pancreatic stellate cell and Cell growth in his study of Cancer research. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Oncology and Hedgehog signaling pathway. Jörg Kleeff has researched Surgery in several fields, including Odds ratio and Pancreatic fistula.
The scientist’s investigation covers issues in Pancreatic cancer, Cancer research, Internal medicine, Pathology and Pancreas. The various areas that Jörg Kleeff examines in his Pancreatic cancer study include Cancer cell, Metastasis and Pancreatic disease. His studies in Cancer cell integrate themes in fields like Ductal cells and Molecular biology.
His Cancer research research incorporates themes from Cell growth, Hepatic stellate cell, Carcinogenesis, Apoptosis and Immunology. His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology, Surgery and Oncology. His research in Pathology tackles topics such as Pancreatitis which are related to areas like Disease.
His scientific interests lie mostly in Pancreatic cancer, Cancer research, Internal medicine, Surgery and Oncology. His study with Pancreatic cancer involves better knowledge in Cancer. His Cancer study combines topics in areas such as Stroma and Asthma.
His Cancer research research is multidisciplinary, relying on both Carcinogenesis, Pancreatic carcinogenesis, Cancer cell, Tumor microenvironment and Metastasis. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Diabetes mellitus, Endocrinology. His Oncology research integrates issues from Locally advanced pancreatic cancer, Chemotherapy, Pancreatic ductal adenocarcinoma, Carcinoma and Survival analysis.
Jörg Kleeff mainly investigates Pancreatic cancer, Internal medicine, Cancer research, Cancer and Oncology. His Pancreatic cancer research includes elements of Survival rate, Pathology, Pancreatectomy, Pancreas and Pancreatitis. He combines subjects such as Gastroenterology and Diabetes mellitus with his study of Internal medicine.
Jörg Kleeff has included themes like Hepatic stellate cell, Cancer cell, CA19-9, Acinar cell and Adenocarcinoma in his Cancer research study. His Cancer study deals with Asthma intersecting with Metabolic syndrome and Odds ratio. His Oncology study incorporates themes from Targeted therapy and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen;Tibor Schuster;Christian Meyer zum Büschenfelde;Helmut Friess.
PLOS Medicine (2010)
Most pancreatic cancer resections are R1 resections.
Irene Esposito;Irene Esposito;Jörg Kleeff;Jörg Kleeff;Frank Bergmann;Caroline Reiser;Caroline Reiser.
Annals of Surgical Oncology (2008)
Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery.
Norbert Hüser;Christoph W. Michalski;Mert Erkan;Tibor Schuster.
Annals of Surgery (2008)
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial.
Markus K. Diener;Christoph M. Seiler;Inga Rossion;Jörg Kleeff.
The Lancet (2011)
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
Mert Erkan;Simone Hausmann;Christoph W. Michalski;Alexander A. Fingerle.
Nature Reviews Gastroenterology & Hepatology (2012)
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
Haruhisa Maruyama;Jörg Kleeff;Stefan Wildi;Helmut Friess.
American Journal of Pathology (1999)
Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases.
Jörg Kleeff;Markus K. Diener;Kaspar Z'graggen;Ulf Hinz.
Annals of Surgery (2008)
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Jörg Kleeff;Toshiyuki Ishiwata;Asli Kumbasar;Asli Kumbasar;Helmut Friess.
Journal of Clinical Investigation (1998)
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
J. Kleeff;T. Ishiwata;H. Maruyama;H. Friess.
Oncogene (1999)
Systematic review and meta‐analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer
C. W. Michalski;J. Kleeff;M. N. Wente;M. K. Diener;M. K. Diener.
British Journal of Surgery (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Hospital Heidelberg
University of California, Irvine
University of Bern
Heidelberg University
Heidelberg University
Ludwig-Maximilians-Universität München
Philipp University of Marburg
Technical University of Munich
University Hospital Heidelberg
Pompeu Fabra University
TU Wien
University of Notre Dame
Indian Institute of Technology Delhi
University of Science and Technology of China
Autonomous University of Barcelona
National Institute for Interdisciplinary Science and Technology
National Taiwan University
Clemson University
University of Siena
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center
Nara Institute of Science and Technology
Charité - University Medicine Berlin
University of Calgary
University of Victoria
University of Tokyo